Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
D2.65 - Clinical relevance of sensitizations to pneumoallergens detected in southern Spain
D2.66 - Deciphering The Molecular Profiles Between Asthma and Urticaria Using Transcriptomic Profiling
D2.67 - Relation betwween IL-6 and asthma in children and adolescent
D2.69 - Symptom Variability in Hypereosinophilic Syndrome: Observations From a Large Cohort Study
D2.70 - The Impact of Comorbidity of respiratory and atopic diseases on Mental Health and Wellbeing: a Community Survey in the US and Eastern Europe
D2.71 - Comprehensive approach to severe bronchial asthma: a case study and the role of biologic therapy
D2.72 - Analysis of asthma prevalence and risk factors in infantile atopic dermatitis using data from the Korean national health insurance serice
D2.73 - Activation-induced marker (AIM) assay to study allergic skin reactions: a case study on p-phenylenediamine
D2.74 - Analytical Verification of House Dust Mite Allergen Assays on the IMMULITE 2000 XPi System*
D2.75 - Allergy to insects in children
D2.76 - When Eosinophilia Persists: Unmasking an Unexpected Diagnosis in a Dupilumab Treated Atopic Dermatitis Patient
D2.77 - A Novel Neural Network for Quantifying Wheal and Erythema in Skin Prick Testing
D2.78 - Hypersensitivity Reactions to Biologics in Patients with Th1- and Th17-Driven Immune-Mediated Diseases: A Series of Three Cases
D3.316 - Impact of chronic urticaria on the quality of life of patients followed up at a university hospital Nis-Serbia
D3.305 - Pediatric and Adult Responses to Fourth-Fold Antihistamine Doses: Insights into Efficacy and Safety
D3.306 - Successful treatment of severe atopic dermatitis in teenage patient with hyper-IgE syndrome (STAT3 mutation)
D3.307 - Experience with Systemic Emergent Therapies for Moderate-to-Severe Atopic Dermatitis: Insights from an Allergy and Clinical Immunology Department
D3.308 - Frailty in elderly with C1 Inhibitor Hereditary Angioedema: first evidence from a monocentric ITACA cohort
D3.309 - Challenges in HAE therapy in children
D3.310 - Hereditary angioedema (HAE) with factor XIIa mutation successfully treated with icatibant as on-demand therapy and lanadelumab for long-term prophylaxis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download